[Congressional Record Volume 167, Number 145 (Tuesday, August 10, 2021)]
[Senate]
[Pages S6310-S6311]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3147. Mr. COTTON (for himself, Mr. McConnell, Mrs. Capito, Ms. 
Ernst, Mr. Hagerty, Mr. Johnson, Mr. Marshall, Mr. Tuberville, and Mr. 
Young) submitted an amendment intended to be proposed by him to the 
concurrent resolution S. Con. Res. 14, setting forth the congressional 
budget for the United States Government for fiscal year 2022 and 
setting forth the appropriate budgetary levels for fiscal years 2023 
through 2031; which was ordered to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO REDUCING 
                   THE AVAILABILITY OF ILLICIT FENTANYL ANALOGUES.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     reducing the availability of illicit fentanyl analogues, 
     which may include changes to the scheduling of fentanyl 
     analogues, such as making permanent the scheduling actions of 
     the Drug Enforcement Administration relating to fentanyl 
     analogues, by the amounts provided in such legislation for 
     those purposes, provided that

[[Page S6311]]

     such legislation would not increase the deficit over either 
     the period of the total of fiscal years 2022 through 2026 or 
     the period of the total of fiscal years 2022 through 2031.
                                 ______